ID   ACHA3_HUMAN             Reviewed;         505 AA.
AC   P32297; Q15823; Q4KMN8; Q86U77; Q96RH3; Q99553; Q9BQ93; Q9BRR4;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 4.
DT   07-APR-2021, entry version 210.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-3;
DE   Flags: Precursor;
GN   Name=CHRNA3; Synonyms=NACHRA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2336208; DOI=10.1016/0304-3940(90)90287-j;
RA   Fornasari D., Chini B., Tarroni P., Clementi F.;
RT   "Molecular cloning of human neuronal nicotinic receptor alpha 3-subunit.";
RL   Neurosci. Lett. 111:351-356(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=1989896; DOI=10.1016/0014-4886(91)90004-v;
RA   Mihovilovic M., Roses A.D.;
RT   "Expression of mRNAs in human thymus coding for the alpha 3 subunit of a
RT   neuronal acetylcholine receptor.";
RL   Exp. Neurol. 111:175-180(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT LEU-23 DEL.
RX   PubMed=8906617; DOI=10.1007/bf02736842;
RA   Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A., Chavez-Noriega L.E.,
RA   Johnson E.C., Velicelebi G., Harpold M.M.;
RT   "Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4
RT   nicotinic acetylcholine receptor subunits and functional expression of the
RT   alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.";
RL   J. Mol. Neurosci. 7:217-228(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT LEU-23 DEL.
RX   PubMed=9009220; DOI=10.1016/s0014-5793(96)01383-x;
RA   Groot Kormelink P.J., Luyten W.H.M.L.;
RT   "Cloning and sequence of full-length cDNAs encoding the human neuronal
RT   nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and
RT   expression of seven nAChR subunits in the human neuroblastoma cell line SH-
RT   SY5Y and/or IMR-32.";
RL   FEBS Lett. 400:309-314(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), AND VARIANT LEU-23 DEL.
RX   PubMed=9921897; DOI=10.1007/s004390050885;
RA   Rempel N., Heyers S., Engels H., Sleegers E., Steinlein O.K.;
RT   "The structures of the human neuronal nicotinic acetylcholine receptor
RT   beta2- and alpha3-subunit genes (CHRNB2 and CHRNA3).";
RL   Hum. Genet. 103:645-653(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11450844; DOI=10.1007/pl00010921;
RA   Lev-Lehman E., Bercovich D., Xu W., Stockton D.W., Beaudet A.L.;
RT   "Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3
RT   and CHRNB4.";
RL   J. Hum. Genet. 46:362-366(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   LEU-23 DEL.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-495 (ISOFORMS 1/2).
RC   TISSUE=Keratinocyte;
RA   Arredondo J., Grando S.A.;
RT   "Cloning cholinergic receptors in human keratinocytes.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 32-505 (ISOFORMS 1/2).
RC   TISSUE=Brain;
RA   Anand R., Lindstrom J.;
RL   Submitted (JUN-1990) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7
RT   nicotinic acetylcholine receptor and distinguish human nicotinic receptor
RT   subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [13]
RP   INTERACTION WITH RIC3.
RX   PubMed=16120769; DOI=10.1124/mol.105.017459;
RA   Lansdell S.J., Gee V.J., Harkness P.C., Doward A.I., Baker E.R., Gibb A.J.,
RA   Millar N.S.;
RT   "RIC-3 enhances functional expression of multiple nicotinic acetylcholine
RT   receptor subtypes in mammalian cells.";
RL   Mol. Pharmacol. 68:1431-1438(2005).
RN   [14]
RP   INVOLVEMENT IN SQTL3 AND LUNG CANCER.
RX   PubMed=18385720; DOI=10.1038/452537a;
RA   Chanock S.J., Hunter D.J.;
RT   "Genomics: when the smoke clears.";
RL   Nature 452:537-538(2008).
RN   [15]
RP   INVOLVEMENT IN SQTL3 AND LUNG CANCER.
RX   PubMed=18385738; DOI=10.1038/nature06885;
RA   Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D.,
RA   Mukeria A., Szeszenia-Dabrowska N., Lissowska J., Rudnai P., Fabianova E.,
RA   Mates D., Bencko V., Foretova L., Janout V., Chen C., Goodman G.,
RA   Field J.K., Liloglou T., Xinarianos G., Cassidy A., McLaughlin J., Liu G.,
RA   Narod S., Krokan H.E., Skorpen F., Elvestad M.B., Hveem K., Vatten L.,
RA   Linseisen J., Clavel-Chapelon F., Vineis P., Bueno-de-Mesquita H.B.,
RA   Lund E., Martinez C., Bingham S., Rasmuson T., Hainaut P., Riboli E.,
RA   Ahrens W., Benhamou S., Lagiou P., Trichopoulos D., Holcatova I.,
RA   Merletti F., Kjaerheim K., Agudo A., Macfarlane G., Talamini R.,
RA   Simonato L., Lowry R., Conway D.I., Znaor A., Healy C., Zelenika D.,
RA   Boland A., Delepine M., Foglio M., Lechner D., Matsuda F., Blanche H.,
RA   Gut I., Heath S., Lathrop M., Brennan P.;
RT   "A susceptibility locus for lung cancer maps to nicotinic acetylcholine
RT   receptor subunit genes on 15q25.";
RL   Nature 452:633-637(2008).
RN   [16]
RP   INVOLVEMENT IN SQTL3 AND LUNG CANCER.
RX   PubMed=18385739; DOI=10.1038/nature06846;
RA   Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A.,
RA   Magnusson K.P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A.,
RA   Stacey S.N., Bergthorsson J.T., Thorlacius S., Gudmundsson J., Jonsson T.,
RA   Jakobsdottir M., Saemundsdottir J., Olafsdottir O., Gudmundsson L.J.,
RA   Bjornsdottir G., Kristjansson K., Skuladottir H., Isaksson H.J.,
RA   Gudbjartsson T., Jones G.T., Mueller T., Gottsaeter A., Flex A.,
RA   Aben K.K.H., de Vegt F., Mulders P.F.A., Isla D., Vidal M.J., Asin L.,
RA   Saez B., Murillo L., Blondal T., Kolbeinsson H., Stefansson J.G.,
RA   Hansdottir I., Runarsdottir V., Pola R., Lindblad B., van Rij A.M.,
RA   Dieplinger B., Haltmayer M., Mayordomo J.I., Kiemeney L.A.,
RA   Matthiasson S.E., Oskarsson H., Tyrfingsson T., Gudbjartsson D.F.,
RA   Gulcher J.R., Jonsson S., Thorsteinsdottir U., Kong A., Stefansson K.;
RT   "A variant associated with nicotine dependence, lung cancer and peripheral
RT   arterial disease.";
RL   Nature 452:638-642(2008).
RN   [17]
RP   INVOLVEMENT IN SQTL3 AND LUNG CANCER.
RX   PubMed=18385676; DOI=10.1038/ng.109;
RA   Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., Dong Q.,
RA   Zhang Q., Gu X., Vijayakrishnan J., Sullivan K., Matakidou A., Wang Y.,
RA   Mills G., Doheny K., Tsai Y.-Y., Chen W.V., Shete S., Spitz M.R.,
RA   Houlston R.S.;
RT   "Genome-wide association scan of tag SNPs identifies a susceptibility locus
RT   for lung cancer at 15q25.1.";
RL   Nat. Genet. 40:616-622(2008).
RN   [18]
RP   INTERACTION WITH LYPD6.
RX   PubMed=27344019; DOI=10.1111/jnc.13718;
RA   Arvaniti M., Jensen M.M., Soni N., Wang H., Klein A.B., Thiriet N.,
RA   Pinborg L.H., Muldoon P.P., Wienecke J., Imad Damaj M., Kohlmeier K.A.,
RA   Gondre-Lewis M.C., Mikkelsen J.D., Thomsen M.S.;
RT   "Functional interaction between Lypd6 and nicotinic acetylcholine
RT   receptors.";
RL   J. Neurochem. 138:806-820(2016).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN BAIPRCK, VARIANT BAIPRCK
RP   340-SER--ALA-505 DEL, AND CHARACTERIZATION OF VARIANT BAIPRCK
RP   340-SER--ALA-505 DEL.
RX   PubMed=31708116; DOI=10.1016/j.ajhg.2019.10.004;
RA   Mann N., Kause F., Henze E.K., Gharpure A., Shril S., Connaughton D.M.,
RA   Nakayama M., Klaembt V., Majmundar A.J., Wu C.W., Kolvenbach C.M., Dai R.,
RA   Chen J., van der Ven A.T., Ityel H., Tooley M.J., Kari J.A., Bownass L.,
RA   El Desoky S., De Franco E., Shalaby M., Tasic V., Bauer S.B., Lee R.S.,
RA   Beckel J.M., Yu W., Mane S.M., Lifton R.P., Reutter H., Ellard S.,
RA   Hibbs R.E., Kawate T., Hildebrandt F.;
RT   "CAKUT and autonomic dysfunction caused by acetylcholine receptor
RT   mutations.";
RL   Am. J. Hum. Genet. 105:1286-1293(2019).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and leads to
CC       opening of an ion-conducting channel across the plasma membrane.
CC       {ECO:0000269|PubMed:31708116}.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of subunits:
CC       alpha and beta. Alpha-3 subunit can be combined to beta-2 or beta-4 to
CC       give rise to functional receptors. Interacts with RIC3; which is
CC       required for proper folding and assembly (PubMed:16120769). Interacts
CC       with LYPD6 (PubMed:27344019). The heteropentamer alpha-3-beta-2
CC       interacts with alpha-conotoxins ImI and ImII (PubMed:15609996). The
CC       heteropentamer alpha-3-beta-2 interacts with alpha-conotoxins ImI,
CC       ImII, PnIA, GID and MII (By similarity). The heteropentamer alpha-3-
CC       beta-4 interacts with the alpha-conotoxin ImI (PubMed:15609996).
CC       {ECO:0000250|UniProtKB:P04757, ECO:0000269|PubMed:15609996,
CC       ECO:0000269|PubMed:16120769, ECO:0000269|PubMed:27344019}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane
CC       {ECO:0000269|PubMed:31708116}; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2;
CC         IsoId=P32297-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P32297-1; Sequence=VSP_037750;
CC       Name=3;
CC         IsoId=P32297-3; Sequence=VSP_037751;
CC   -!- POLYMORPHISM: Genetic variations in CHRNA3 have been associated with
CC       susceptibility to smoking-related behavioral traits and lung cancer,
CC       contributing to the smoking quantitative trait locus 3 (SQTL3)
CC       [MIM:612052].
CC   -!- DISEASE: Bladder dysfunction, autonomic, with impaired pupillary reflex
CC       and secondary CAKUT (BAIPRCK) [MIM:191800]: An autosomal recessive
CC       disease characterized by impaired innervation and autonomic dysfunction
CC       of the urinary bladder, hydronephrosis, vesicoureteral reflux, small
CC       kidneys, recurrent urinary tract infections, and progressive renal
CC       insufficiency. Additional autonomic features are impaired pupillary
CC       reflex and orthostatic hypotension. The disease manifests in utero or
CC       early childhood. {ECO:0000269|PubMed:31708116}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-3/CHRNA3 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M86383; AAC84176.1; -; mRNA.
DR   EMBL; M37981; AAA59942.1; -; mRNA.
DR   EMBL; U62432; AAB40110.1; -; mRNA.
DR   EMBL; Y08418; CAA69695.1; -; mRNA.
DR   EMBL; AJ007783; CAA07682.1; -; Genomic_DNA.
DR   EMBL; AJ007784; CAA07682.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007785; CAA07682.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007786; CAA07682.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007787; CAA07682.1; JOINED; Genomic_DNA.
DR   EMBL; BT006646; AAP35292.1; -; mRNA.
DR   EMBL; BT006897; AAP35543.1; -; mRNA.
DR   EMBL; AC027228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC067863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000513; AAH00513.1; -; mRNA.
DR   EMBL; BC001642; AAH01642.1; -; mRNA.
DR   EMBL; BC002996; AAH02996.1; -; mRNA.
DR   EMBL; BC006114; AAH06114.1; -; mRNA.
DR   EMBL; BC098443; AAH98443.1; -; mRNA.
DR   EMBL; AF385584; AAK68110.1; -; mRNA.
DR   EMBL; X53559; CAA37625.1; -; mRNA.
DR   CCDS; CCDS10305.1; -. [P32297-2]
DR   CCDS; CCDS53964.1; -. [P32297-3]
DR   PIR; A37040; A37040.
DR   PIR; A53956; A53956.
DR   RefSeq; NP_000734.2; NM_000743.4. [P32297-2]
DR   RefSeq; NP_001160166.1; NM_001166694.1. [P32297-3]
DR   PDB; 4ZK4; X-ray; 1.90 A; A/B/C/D/E=215-230.
DR   PDB; 5SYO; X-ray; 2.00 A; A/B/C/D/E=215-230.
DR   PDB; 5TVC; X-ray; 1.93 A; A/B/C/D/E=215-230.
DR   PDB; 6PV7; EM; 3.34 A; A/D=32-378, A/D=434-505.
DR   PDB; 6PV8; EM; 3.87 A; A/D=32-378, A/D=434-505.
DR   PDBsum; 4ZK4; -.
DR   PDBsum; 5SYO; -.
DR   PDBsum; 5TVC; -.
DR   PDBsum; 6PV7; -.
DR   PDBsum; 6PV8; -.
DR   SMR; P32297; -.
DR   BioGRID; 107558; 31.
DR   ComplexPortal; CPX-187; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha5-beta2.
DR   ComplexPortal; CPX-210; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha5-beta4.
DR   ComplexPortal; CPX-213; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha6-beta4.
DR   ComplexPortal; CPX-2192; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha6-beta2-beta3.
DR   ComplexPortal; CPX-2193; Neuronal nicotinic acetylcholine receptor complex, alpha3-beta2.
DR   ComplexPortal; CPX-2200; Neuronal nicotinic acetylcholine receptor complex, alpha3-beta4.
DR   IntAct; P32297; 31.
DR   STRING; 9606.ENSP00000315602; -.
DR   BindingDB; P32297; -.
DR   ChEMBL; CHEMBL3068; -.
DR   DrugBank; DB00915; Amantadine.
DR   DrugBank; DB01156; Bupropion.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB09028; Cytisine.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB07720; Epibatidine.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB05710; Gantacurium.
DR   DrugBank; DB01227; Levacetylmethadol.
DR   DrugBank; DB00848; Levamisole.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01090; Pentolinium.
DR   DrugBank; DB01273; Varenicline.
DR   DrugCentral; P32297; -.
DR   GuidetoPHARMACOLOGY; 464; -.
DR   GlyGen; P32297; 2 sites.
DR   iPTMnet; P32297; -.
DR   PhosphoSitePlus; P32297; -.
DR   BioMuta; CHRNA3; -.
DR   DMDM; 254763435; -.
DR   MassIVE; P32297; -.
DR   PaxDb; P32297; -.
DR   PeptideAtlas; P32297; -.
DR   PRIDE; P32297; -.
DR   ProteomicsDB; 54858; -. [P32297-2]
DR   ProteomicsDB; 54859; -. [P32297-1]
DR   ProteomicsDB; 54860; -. [P32297-3]
DR   Antibodypedia; 15113; 297 antibodies.
DR   DNASU; 1136; -.
DR   Ensembl; ENST00000326828; ENSP00000315602; ENSG00000080644. [P32297-2]
DR   Ensembl; ENST00000348639; ENSP00000267951; ENSG00000080644. [P32297-3]
DR   Ensembl; ENST00000559658; ENSP00000452896; ENSG00000080644. [P32297-2]
DR   GeneID; 1136; -.
DR   KEGG; hsa:1136; -.
DR   UCSC; uc002beb.4; human. [P32297-2]
DR   CTD; 1136; -.
DR   DisGeNET; 1136; -.
DR   GeneCards; CHRNA3; -.
DR   HGNC; HGNC:1957; CHRNA3.
DR   HPA; ENSG00000080644; Group enriched (adrenal gland, lymphoid tissue, retina).
DR   MalaCards; CHRNA3; -.
DR   MIM; 118503; gene.
DR   MIM; 191800; phenotype.
DR   MIM; 612052; phenotype.
DR   neXtProt; NX_P32297; -.
DR   OpenTargets; ENSG00000080644; -.
DR   PharmGKB; PA113; -.
DR   VEuPathDB; HostDB:ENSG00000080644.15; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   GeneTree; ENSGT00940000158487; -.
DR   HOGENOM; CLU_018074_1_0_1; -.
DR   InParanoid; P32297; -.
DR   OMA; QKPRPFY; -.
DR   OrthoDB; 381858at2759; -.
DR   PhylomeDB; P32297; -.
DR   TreeFam; TF315605; -.
DR   PathwayCommons; P32297; -.
DR   Reactome; R-HSA-629587; Highly sodium permeable postsynaptic acetylcholine nicotinic receptors.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-HSA-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   BioGRID-ORCS; 1136; 8 hits in 984 CRISPR screens.
DR   ChiTaRS; CHRNA3; human.
DR   GeneWiki; CHRNA3; -.
DR   GenomeRNAi; 1136; -.
DR   Pharos; P32297; Tclin.
DR   PRO; PR:P32297; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P32297; protein.
DR   Bgee; ENSG00000080644; Expressed in pigmented layer of retina and 156 other tissues.
DR   ExpressionAtlas; P32297; baseline and differential.
DR   Genevisible; P32297; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0044853; C:plasma membrane raft; ISS:ARUK-UCL.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0042166; F:acetylcholine binding; IC:UniProtKB.
DR   GO; GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; ISS:ARUK-UCL.
DR   GO; GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISS:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006811; P:ion transport; NAS:UniProtKB.
DR   GO; GO:0007626; P:locomotory behavior; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IMP:UniProtKB.
DR   GO; GO:0050877; P:nervous system process; IBA:GO_Central.
DR   GO; GO:0014056; P:regulation of acetylcholine secretion, neurotransmission; ISS:UniProtKB.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; ISS:UniProtKB.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; ISS:UniProtKB.
DR   GO; GO:1905144; P:response to acetylcholine; ISS:ARUK-UCL.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0060084; P:synaptic transmission involved in micturition; IMP:UniProtKB.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISS:UniProtKB.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Disease variant; Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..505
FT                   /note="Neuronal acetylcholine receptor subunit alpha-3"
FT                   /id="PRO_0000000346"
FT   TOPO_DOM        32..240
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        241..265
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        273..291
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        307..328
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        329..477
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        478..497
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04757"
FT   MOD_RES         416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04757"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        159..173
FT                   /evidence="ECO:0000250"
FT   DISULFID        223..224
FT                   /note="Associated with receptor activation"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..6
FT                   /note="MGSGPL -> MALAV (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:1989896,
FT                   ECO:0000303|PubMed:2336208, ECO:0000303|PubMed:9009220"
FT                   /id="VSP_037750"
FT   VAR_SEQ         464..505
FT                   /note="IQDDWKYVAMVIDRIFLWVFTLVCILGTAGLFLQPLMAREDA -> EQKAQE
FT                   IQQLKRKEKSTETSDQEPGL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.7"
FT                   /id="VSP_037751"
FT   VARIANT         23
FT                   /note="Missing"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8906617, ECO:0000269|PubMed:9009220,
FT                   ECO:0000269|PubMed:9921897"
FT                   /id="VAR_013240"
FT   VARIANT         37
FT                   /note="R -> H (in dbSNP:rs8192475)"
FT                   /id="VAR_059110"
FT   VARIANT         340..505
FT                   /note="Missing (in BAIPRCK; loss-of-function variant
FT                   affecting ion transmembrane transport in response to
FT                   acetylcholine; does not localize to plasma membrane)"
FT                   /evidence="ECO:0000269|PubMed:31708116"
FT                   /id="VAR_083543"
FT   CONFLICT        5..14
FT                   /note="PLSLPLALSP -> ALAAPGAVA (in Ref. 2; AAA59942)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12..15
FT                   /note="LSPP -> CRA (in Ref. 1; AAC84176)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        102
FT                   /note="D -> G (in Ref. 1; AAC84176)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134..135
FT                   /note="DD -> TT (in Ref. 1; AAC84176)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        237
FT                   /note="I -> S (in Ref. 1; AAC84176)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        432
FT                   /note="L -> V (in Ref. 1; AAC84176)"
FT                   /evidence="ECO:0000305"
FT   HELIX           33..42
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          60..75
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   TURN            76..79
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          80..92
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          94..96
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   TURN            100..105
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          108..112
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   TURN            113..115
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          124..126
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          137..142
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          145..149
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          152..157
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          164..168
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          170..177
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          179..181
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   TURN            184..186
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          187..195
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          205..211
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   STRAND          215..220
FT                   /evidence="ECO:0007744|PDB:4ZK4"
FT   STRAND          225..230
FT                   /evidence="ECO:0007744|PDB:4ZK4"
FT   HELIX           245..249
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           250..256
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           261..264
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           272..293
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           303..329
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   TURN            333..335
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           341..344
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           345..349
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           350..353
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   HELIX           442..493
FT                   /evidence="ECO:0007744|PDB:6PV7"
FT   TURN            494..499
FT                   /evidence="ECO:0007744|PDB:6PV7"
SQ   SEQUENCE   505 AA;  57480 MW;  478D7712D59ACB2D CRC64;
     MGSGPLSLPL ALSPPRLLLL LLLSLLPVAR ASEAEHRLFE RLFEDYNEII RPVANVSDPV
     IIHFEVSMSQ LVKVDEVNQI METNLWLKQI WNDYKLKWNP SDYGGAEFMR VPAQKIWKPD
     IVLYNNAVGD FQVDDKTKAL LKYTGEVTWI PPAIFKSSCK IDVTYFPFDY QNCTMKFGSW
     SYDKAKIDLV LIGSSMNLKD YWESGEWAII KAPGYKHDIK YNCCEEIYPD ITYSLYIRRL
     PLFYTINLII PCLLISFLTV LVFYLPSDCG EKVTLCISVL LSLTVFLLVI TETIPSTSLV
     IPLIGEYLLF TMIFVTLSIV ITVFVLNVHY RTPTTHTMPS WVKTVFLNLL PRVMFMTRPT
     SNEGNAQKPR PLYGAELSNL NCFSRAESKG CKEGYPCQDG MCGYCHHRRI KISNFSANLT
     RSSSSESVDA VLSLSALSPE IKEAIQSVKY IAENMKAQNE AKEIQDDWKY VAMVIDRIFL
     WVFTLVCILG TAGLFLQPLM AREDA
//
